Nicholas A. Saccomano, President and CEO at OnKure Therapeutics, Inc. (OKUR), sold 172 shares at $4.16 ($715) on 2026-03-23, disclosed to the SEC on 2026-03-24.
Open-market sale of $715 OKUR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.16 | 86 | $357 | 50.0% |
| 2 | $4.16 | 86 | $358 | 50.0% |
| Total | $4.16 avg | 172 | $715 | 100% |
| Filing → |
| OKUR | SELL | 2025-12-23 | $258 | — | Filing → |
| OKUR | SELL | 2025-09-24 | $231 | — | Filing → |
| OKUR | SELL | 2025-06-25 | $209 | — | Filing → |